Symbiotec Pharmalab Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
25 Sep 2026Beacon Trusteeship Limited
Reg29(1)
Acquisition Others 4,748,208
7.38%
— 7.38% No
24 Sep 2026Beacon Trusteeship Limited acting in its capacity as the debenture trustee
Reg29(1)
Acquisition Others 3,493,464
5.44%
— 5.44% No
21 Sep 2026Mirae Asset Mutual Fund
Reg29(1)
Acquisition Open Market 3,497,420
5.44%
— 6.21% No
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.